Italia markets closed

BMY Sep 2024 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,1100-0,0900 (-2,81%)
Alla chiusura: 03:23PM EDT
Schermo intero
Chiusura precedente3,2000
Aperto3,0500
Denaro3,0000
Lettera3,1000
Prezzo d'esercizio45,00
Scadenza2024-09-20
Min-Max giorno3,0500 - 3,1500
Contratto - Min-MaxN/D
Volume21
Open Interest2,71k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri